Cargando…
Multiple sclerosis pharmacogenetics: personalized approach towards tailored therapeutics
Multiple sclerosis (MS) is a chronic autoimmune disease, where T-cells attack the myelin sheath in the central nervous system (CNS), characterized by relapsing-remitting episodes, or gradually increasing severity of symptoms and disability that accumulate over time. While current MS therapies have b...
Autores principales: | Grossman, Iris, Miller, Ariel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405323/ https://www.ncbi.nlm.nih.gov/pubmed/23199067 http://dx.doi.org/10.1007/s13167-010-0020-7 |
Ejemplares similares
-
Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicine
por: Mannino, Gaia Chiara, et al.
Publicado: (2019) -
Targeting Phosphodiesterases—Towards a Tailor-Made Approach in Multiple Sclerosis Treatment
por: Schepers, Melissa, et al.
Publicado: (2019) -
A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis
por: Ross, Colin J., et al.
Publicado: (2017) -
Pharmacogenetics and pharmacogenomics in glaucoma therapeutics: the way to personalized therapy
por: Liao, Shiyu, et al.
Publicado: (2023) -
Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine
por: Micaglio, Emanuele, et al.
Publicado: (2021)